UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Increases Stock Holdings in Ventas, Inc. $VTR

Posted by Stanley Muller on Aug 31st, 2026

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in shares of Ventas, Inc. (NYSE:VTR – Free Report) by 5.5% in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 4,981,404 shares of the real estate investment trust’s stock after buying an additional 258,859 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned approximately 0.97% of Ventas worth $442,349,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Deutsche Bank AG lifted its holdings in shares of Ventas by 0.7% in the fourth quarter. Deutsche Bank AG now owns 3,904,293 shares of the real estate investment trust’s stock valued at $302,114,000 after purchasing an additional 27,688 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Ventas by 2.5% during the 4th quarter. Bank of New York Mellon Corp now owns 2,868,962 shares of the real estate investment trust’s stock worth $222,000,000 after purchasing an additional 70,459 shares in the last quarter. Norges Bank purchased a new position in shares of Ventas during the 4th quarter worth approximately $474,571,000. Mitsubishi UFJ Asset Management Co. Ltd. raised its position in shares of Ventas by 7.4% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,346,111 shares of the real estate investment trust’s stock worth $104,095,000 after purchasing an additional 92,236 shares during the last quarter. Finally, Cbre Investment Management Listed Real Assets LLC raised its position in shares of Ventas by 5.8% during the 4th quarter. Cbre Investment Management Listed Real Assets LLC now owns 1,851,968 shares of the real estate investment trust’s stock worth $143,305,000 after purchasing an additional 101,370 shares during the last quarter. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several equities analysts have weighed in on the company. Wells Fargo & Company raised their price target on Ventas from $93.00 to $96.00 and gave the stock an “overweight” rating in a research report on Monday, June 1st. Cantor Fitzgerald increased their price objective on Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Mizuho lifted their price objective on Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 22nd. KeyCorp boosted their target price on shares of Ventas from $90.00 to $95.00 and gave the company an “overweight” rating in a research note on Thursday, May 7th. Finally, The Goldman Sachs Group restated a “buy” rating and issued a $110.00 target price on shares of Ventas in a report on Tuesday, May 19th. Fourteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, Ventas has an average rating of “Moderate Buy” and a consensus price target of $98.00.

Check Out Our Latest Analysis on Ventas

Insider Buying and Selling

In other news, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction on Wednesday, June 3rd. The stock was bought at an average price of $78.81 per share, with a total value of $197,025.00. Following the completion of the transaction, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. The trade was a 14.97% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Company insiders own 0.53% of the company’s stock.

Ventas Stock Performance

NYSE:VTR opened at $91.78 on Monday. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The company has a market cap of $47.08 billion, a P/E ratio of 169.96, a P/E/G ratio of 2.11 and a beta of 0.69. The company has a quick ratio of 0.44, a current ratio of 0.44 and a debt-to-equity ratio of 0.86. The firm’s 50 day moving average is $92.42 and its two-hundred day moving average is $87.61.

Ventas (NYSE:VTR – Get Free Report) last announced its quarterly earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 EPS for the quarter, topping the consensus estimate of $0.96 by $0.01. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The company had revenue of $1.73 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same period in the prior year, the firm posted $0.87 earnings per share. The firm’s revenue was up 21.7% on a year-over-year basis. Analysts expect that Ventas, Inc. will post 3.89 EPS for the current year.

About Ventas

(Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.